Clinical Trial Update: Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating insulin degludec and insulin glargine U100 for management of hospitalized and discharged patients with type 2 diabetes; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)
• insulin glargine U100 (insulin glargine)

Snippet

Sponsor: Emory University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2022-03-31